ClinicalTrials.gov record
Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
ClinicalTrials.gov ID: NCT00677807
Public ClinicalTrials.gov record NCT00677807. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 26-week Extension to a 26-week Treatment, Multicenter, Randomized, Double-blind, Placebo-controlled, Adaptive, Seamless, Parallel-group Study to Assess Safety, Tolerability and Efficacy of Two Doses of Indacaterol (150 and 300 µg o.d.) in Patients With Chronic Obstructive Pulmonary Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study evaluated the 1 year safety, tolerability and efficacy of indacaterol against placebo in the treatment of Chronic Obstructive Pulmonary Disease (COPD) patients
Study identification
- NCT ID
- NCT00677807
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 415 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2008 (Type not available)
- Primary completion
- Mar 2009 (Actual)
- Completion
- Mar 2009 (Actual)
- Last update posted
- Aug 22, 2011
2008 – 2009
United States locations
- U.S. sites
- 93
- U.S. states
- 35
- U.S. cities
- 86
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novartis Investigative Site | Homewood | Alabama | 35209-6870 | — |
| Novartis Investigative Site | Jasper | Alabama | 35501 | — |
| Novartis Investigative Site | Phoenix | Arizona | 85013 | — |
| Novartis Investigative Site | Tucson | Arizona | 85712 | — |
| Novartis Investigative Site | Pine Bluff | Arkansas | 71603 | — |
| Novartis Investigative Site | Encinitas | California | 92024-1332 | — |
| Novartis Investigative SIte | Fullerton | California | 92835 | — |
| Novartis Investigative Site | Orange | California | 92869 | — |
| Novartis Investigative Site | Riverside | California | 92506 | — |
| Novartis Investigative Site | Spring Valley | California | 91978 | — |
| Novartis Investigative site | Fort Collins | Colorado | 80528 | — |
| Novartis Investigative site | Golden | Colorado | 80401 | — |
| Novartis Investigative Site | Wheat Ridge | Colorado | 80033 | — |
| Novartis Investigative Site | Clearwater | Florida | 33765 | — |
| Novartis Investigative Site | Largo | Florida | 33770 | — |
| Novartis Investigative Site | Pensacola | Florida | 32504 | — |
| Novartis Investigative Site | Rockledge | Florida | 32955 | — |
| Novartis Investigative Site | South Miami | Florida | 33143 | — |
| Novartis Investigative Site | Tamarac | Florida | 33321 | — |
| Novartis Investigative Site | Tampa | Florida | 33603 | — |
| Novartis Investigative Site | Atlanta | Georgia | 30342 | — |
| Novartis Investigative Site | Marietta | Georgia | 30060 | — |
| Novartis Investigative Site | Normal | Illinois | 61761 | — |
| Novartis Investigative Site | O'Fallon | Illinois | 62269 | — |
| Novartis Investigative Site | River Forest | Illinois | 60305 | — |
| Novartis Investigative Site | Indianapolis | Indiana | 46256 | — |
| Novartis Investigative Site | Iowa City | Iowa | 52240 | — |
| Novartis Investigative Site | Iowa City | Iowa | 52242 | — |
| Novartis Investigative Site | Topeka | Kansas | 66606 | — |
| Novartis Investigative Site | Crescent Springs | Kentucky | 41017 | — |
| Novartis Investigative Site | Lexington | Kentucky | 40504 | — |
| Novartis Investigative Site | Lexington | Kentucky | 40536 | — |
| Novartis Investigative Site | Lafayette | Louisiana | 70503 | — |
| Novartis Investigative Site | Metaire | Louisiana | 70002 | — |
| Novartis Investigative site | New Orleans | Louisiana | 70112 | — |
| Novartis Investigative Site | Biddeford | Maine | 04005 | — |
| Novartis Investgative Site | Clarkston | Michigan | 48346 | — |
| Novartis Investigative Site | Flint | Michigan | 48532 | — |
| Novartis Investigative Site | Livonia | Michigan | 48152 | — |
| Novartis Investigative site | Troy | Michigan | 48085 | — |
| Novartis Investigative Site | Minneapolis | Minnesota | 55402 | — |
| Novartis Investigative Site | Minneapolis | Minnesota | 55407 | — |
| Novartis Investigative Site | Rochester | Minnesota | 55905 | — |
| Novartis Investigative Site | Chesterfield | Missouri | 63017 | — |
| Novartis Investigative Site | Columbia | Missouri | 65212 | — |
| Novartis Investigative Site | Kansas City | Missouri | 64108-2677 | — |
| Novartis Investigative Site | St Louis | Missouri | 63141 | — |
| Novartis Investigative Site | Billings | Montana | 59102 | — |
| Novartis Investigative Site | Kalispell | Montana | 59901 | — |
| Novartis Investigative Site | Lincoln | Nebraska | 68510 | — |
| Novartis Investigative Site | Omaha | Nebraska | 68130 | — |
| Novartis Investigative Site | Omaha | Nebraska | 68134 | — |
| Novartis Investigative Site | Omaha | Nebraska | 68198-5885 | — |
| Novartis Investigative Site | Papillion | Nebraska | 68046 | — |
| Novartis Investigative site | Henderson | Nevada | 89014 | — |
| Novartis Investigative site | Summit | New Jersey | 07901 | — |
| Novartis Investigative Site | Elmira | New York | 14905 | — |
| Novartis Investigative site | New York | New York | 10016 | — |
| Novartis Investigative Site | Rochester | New York | 14618-2638 | — |
| Novartis Investigative Site | Charlotte | North Carolina | 28207 | — |
| Novartis Investigative Site | Shelby | North Carolina | 28150 | — |
| Novartis Investigative Site | Winston-Salem | North Carolina | 27103 | — |
| Novartis Investigative Site | Fargo | North Dakota | 58122 | — |
| Novartis Investigative Site | Cincinnati | Ohio | 45245 | — |
| Novartis Investigative Site | Cleveland | Ohio | 44109-1998 | — |
| Novartis Investigative Site | Columbus | Ohio | 43213 | — |
| Novartis Investigative Site | Columbus | Ohio | 43215 | — |
| Novartis Investigative Site | Marion | Ohio | 43302 | — |
| Novartis Investigative Site | Sylvania | Ohio | 43650 | — |
| Novartis Investigative Site | Thornville | Ohio | 43076 | — |
| Novartis Investigative Site | Zanesville | Ohio | 43701 | — |
| Novartis Investigative Site | Oklahoma City | Oklahoma | 73104 | — |
| Novartis Investigative Site | Tulsa | Oklahoma | 74135-2920 | — |
| Novartis Investigative Site | Eugene | Oregon | 97404-3233 | — |
| Novartis Investigative Site | Medford | Oregon | 97504-8741 | — |
| Novartis Investigative Site | Erie | Pennsylvania | 16506 | — |
| Novartis Investigative Site | Pittsburgh | Pennsylvania | 15221 | — |
| Novartis Investigative Site | Pittsburgh | Pennsylvania | 15243 | — |
| Novartis Investigative site | Cranston | Rhode Island | 02920 | — |
| Novartis Investigative Site | Cumberland | Rhode Island | 02864 | — |
| Novartis Investigative Site | Greenville | South Carolina | 29615 | — |
| Novartis Investigative Site | Johnson City | Tennessee | 37601 | — |
| Novartis Investigative Site | Corsicana | Texas | 75110 | — |
| Novartis Investigative Site | Dallas | Texas | 75231 | — |
| Novartis Investigative site | El Paso | Texas | 79902 | — |
| Novartis Investigative Site | Fort Worth | Texas | 76104 | — |
| Novartis Investigative Site | San Antonio | Texas | 78229 | — |
| Novartis Investigative Site | Abingdon | Virginia | 24210 | — |
| Novartis Investigative site | Lynchburg | Virginia | 24501 | — |
| Novartis Investigative Site | Richmond | Virginia | 23249 | — |
| Novartis Investigative Site | Bellingham | Washington | 98225 | — |
| Novartis Investigative site | Spokane | Washington | 99216 | — |
| Novartis Investigative Site | Milwaukee | Wisconsin | 53209-0996 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 97 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00677807, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 22, 2011 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00677807 live on ClinicalTrials.gov.